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Abstract
Objective: To investigate demographic and clinical factors associated with employment in MS.
Methods: The study included 213 (89.9%) of all MS patients in Sogn and Fjordane County, Western Norway at December
31st 2010. The patients underwent clinical evaluation, structured interviews and completed self-reported questionnaires.
Demographic and clinical factors were compared between patients being employed versus patients being unemployed and
according to disease course of MS. Logistic regression analysis was used to identify factors independently associated with
current employment.
Results: After a mean disease duration of almost 19 years, 45% of the population was currently full-time or part- time
employed. Patients with relapsing –remitting MS (RRMS) had higher employment rate than patients with secondary (SPMS)
and primary progressive (PPMS). Higher educated MS patients with lower age at onset, shorter disease duration, less severe
disability and less fatigue were most likely to be employed.
Conclusions: Nearly half of all MS patients were still employed after almost two decades of having MS. Lower age at onset,
shorter disease duration, higher education, less fatigue and less disability were independently associated with current
employment. These key clinical and demographic factors are important to understand the reasons to work ability in MS. The
findings highlight the need for environmental adjustments at the workplace to accommodate individual ’s needs in order to
improve working ability among MS patients.
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Introduction
Multiple Sclerosis (MS) is a chronic debilitating central nervous
system (CNS) illness that is associated with a high unemployment
rate in early adulthood [1]. Inflammation, demyelination and
axonal damage are pathological hallmarks giving rise to the
characteristic multifocal CNS lesions seen in MS [2]. The
symptoms that come along with having MS reflect the multifocal
nature of the pathology, by showing a wide individual variation
and severity. In dealing with the unpredictable nature of disease
progression, the individual affected is left with a high degree of
uncertainty about future occupational demands and work ability.
The school-to-work transition may pose particular challenges for
MS patients who are physically disabled or have a cognitive
dysfunction. MS is one of the leading causes of non-traumatic
disability affecting young adults in Europe and the USA, and the
degree of physical disability has shown to be a strong predictor of
work ability [3–5]. Non-motor symptoms like pain, fatigue and
memory impairment as well as demographic factors such as age
and educational background have also shown significant impact
on employment status in MS [6,7]. Thus, employment may be
regarded as a marker of overall functioning of the individual
patient, and have also important impact on quality of life (QoL)
[8]. Several studies have investigated and described demographic
and clinical features associated with employment status in different
cohorts of MS patients [9–11]. However, we are not aware of any
studies that have investigated employment status in a county based
MS population and its subsequent clinical subtypes: relapsing-
remitting MS (RRMS), secondary progressive MS (SPMS) and
primary progressive MS (PPMS). To further explore MS patient’s
ability to work, we therefore investigated demographic and clinical
factors influencing employment status in a population based MS
cohort from Sogn and Fjordane County, Western Norway.
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Materials and Methods
Ethics Statement
Written informed consent was obtained by all the participants
and the study was approved by the local regional committee for
research ethics, Western Norway.
Patients
The study was conducted during 2008–2010 at the Central
Hospital of Sogn and Fjordane County in the city of Førde,
Western Norway. All MS patients in the county are diagnosed,
registered and receive regular follow-up visits at the Department of
Neurology at this Hospital. All prevalent MS patients in the county
at December 31st 2010 were invited to participate in an extensive
study of the clinical and demographic impact of MS. A total of 213
of 237 (89.9%) MS patients in Sogn and Fjordane County
consented for participation and were available for inclusion in the
study. The patients fulfilled the diagnostic criteria of McDonald,
and were classified according to disease course into RRMS, SPMS
and PPMS. Marital status, education, disease course, onset
symptoms, chronic pain and disability were registered or scored
at time of interview and examination. All other data were obtained
from patient self-assessment questionnaires. Demographic and
clinical data were compared between subtypes of MS and between
patients being employed versus patients being unemployed.
Written informed consent was obtained by all the participants
and the study was approved by the local regional committee for
research ethics, Western Norway.
Employment status
Current employment status was recorded, dichotomized and
defined as employed (full time and part time) or not employed. Full
time work for Norwegian employees is defined as 37.5 hour per
week. Reasons for not being employed were divided into six
different categories: sick leave; unemployment; disability pension;
retirement pension; education and others. Type of occupation was
registered and classified into two categories based on manual
physical strength; light physical work (administration, teacher,
secretary) and heavy physical work (nurse, craftsman, farmer etc.)
[12,13]. Age and gender specific employment rates of the general
population in Sogn og Fjordane County in 2010 were obtained
from Statistics Norway, and compared to the employment rates of
the MS patients.
Demographic characteristics of patient population
We recorded demographic data on age, gender, education and
marital status. Education was recorded and categorized into lower
educational levels #12 years (primary, secondary and high school)
and higher educational levels .12 years (college, university).
Clinical characteristics
Year and symptoms of onset, disease course categorized as
RRMS, SPMS and PPMS, fatigue, disability, presence of chronic
pain, depression and use of disease modifying treatment (DMT)
were recorded.
Onset symptoms were initially categorized into seven groups
according to Kurtzke’s Functional Systems; visual, sensory,
brainstem, cerebellar, pyramidal, bowel/bladder and others, but
were further merged into three groups (visual-sensory, brainstem-
cerebellar, pyramidal) due to small numbers.
Fatigue was assessed by the Fatigue Severity Scale (FSS), which
is one of the most widely used fatigue severity specific question-
naires in MS [14]. The Norwegian version of the FSS is validated
and has previously shown satisfactory psychometric properties
[15].
The patients were clinically examined, and neurological
disability score was registered by use of the Expanded Disability
Status Scale (EDSS) [16].
Chronic pain was recorded as constant or intermittent pain
experienced every day over the past 3 months. For analytical
purposes, pain was dichotomized into present or not, regardless of
localization or type of pain.
Depression was assessed according to the original Beck
Depression Inventory (BDI) [17]. This score range from 0–63
and scores 0–9 are considered normal, scores 10–19 as mild
depression, scores 20–29 as moderate depression and scores from
30–63 as severe depression. According to Kendall, AT Beck and
co-workers in ‘‘Issues and recommendations regarding use of the
Beck depression inventory’’ the term depression are recommended
used for patients with scores from 20–30 (moderate depression)
and patients with scores from 10–19 may be referred to as
‘‘dysphoric’’. Based on the BDI score, the patients were therefore
categorized as not being depressed (score 0–19) and depressed
(score 20–63) [18].
Anxiety was assessed according to Beck Anxiety Inventory (BAI)
[19]. This score range from 0–63 and scores 0–15 are considered
minimal or mild anxiety and scores from 16–25 as moderate
anxiety and scores from 26–63 as severe anxiety. Based on the BAI
scores, the patients were therefore categorized as not having
anxiety (scores 0–15) and having anxiety (scores 16–63) [19].
Type of disease modifying treatment (DMT) (interferon beta,
glatiramer acetate, natalizumab, fingolimod, mitoxantrone) was
analyzed as present use or not, but not further classified, due to
small group sizes.
Statistical analysis
For continuous variables following a normal distribution One -
Way analysis of variance (ANOVA) was used to compare different
types of MS, age at onset and disease duration. Non parametric
test of Kruskal-Wallis was applied for ordinal and continuous
variables of non-normality (time from onset to diagnosis, fatigue
and disability). Fisher exact test was used to compare categorical
variables (gender, married/cohabitant, education, onset symp-
toms, depression, anxiety, chronic pain and disease modulating
therapy). Shapiro –Wilk test in combination with inspection of the
normal Q-Q plots were used to assess the assumption of normality.
We used a binary regression model to estimate odds ratios (ORs)
in order to identify possible independent factors associated with
the outcome variable (being employed). Building a regression
model included several steps as described by Hosmer and
Lemeshow [18]. The selection process of covariates related to
employment began with a univariate analysis. Any variable with
P,0.25 was selected as a candidate for the multivariate model
based on the Wald test [20]. More traditional levels of p,0.05 can
fail in identifying variables known to be important [20]. All
candidates were included in a model and one by one non-
significant variables were removed until the final model containing
all significant variables. In this process large changes in OR for the
remaining variables were thoroughly inspected. The Hosmer-
Lemeshow goodness of fit test was used to test good fit for our
regression model. Further, cross-tabulation and analysis of missing
data in the multivariate analysis with respect to age at onset,
married status and gender were performed, and there were no
significant differences recorded between missing data to the cases
included in the analysis. Statistical significance was defined as p#
0.05, two tailed tests. The data were analysed by using SPSS
software for Windows (IBM SPSS Statistics21).
Employment among Patients with Multiple Sclerosis-A Population Study
PLOS ONE | www.plosone.org 2 July 2014 | Volume 9 | Issue 7 | e103317
Results
Demographic and clinical characteristics in MS; RRMS,
SPMS and PPMS
All 213 MS patients were available for socio-demographic
analysis; among them 147 women and 66 men, giving a female:
male ratio of 2.2:1 (Table 1). The initial courses were RRMS in
186 patients, of whom 112 still had RRMS, whereas 74 patients
had developed SPMS. A total of 27 patients had PPMS. Mean age
of the cohort was 49.8 (612.0) years, and significant differences
between RRMS (43.269.9), SPMS (55.8610.1) and PPMS
(60.967.9) were revealed (p,0.001) (data not shown). The mean
disease duration for the entire cohort was 18.9 (611.5) years and
significant variations according to subtype of MS were noted;
RRMS (13.9 years), SPMS (27.3 years), PPMS (16.9 years) (p,
0.001). Median time from onset to MS-diagnosis for the whole
cohort was 4.0 years and we found distinct differences between
subtypes of MS; RRMS (3.0 years), SPMS (7.0 years) and PPMS
(2.0 years) (p = 0.001). There were no differences regarding marital
status (p = 0.29) or levels of education (p= 0.37) between MS
subtypes.
Both frequency of visual/sensory onset symptoms (p= 0.001)
and mean level of neurological disability (p,0.001) differed
significantly among subtypes of MS (Table 1). As expected, more
frequent use of disease modifying treatment (DMT) was registered
in patients with RRMS than in patients with progressive types of
MS (p,0.001). About 55.9% (95/197) of patients reported having
chronic pain, but no variation according to subtypes of MS was
seen (p = 0.47). More patients reported presence of anxiety
(18.7%) than depressive (6.5%) symptoms, without differences
between MS subtypes (p = 0.41, p= 0.30). Only ten patients
received antidepressants, of which 9 used selective serotonin
reuptake inhibitor and one a tricyclic agent.
Employment rate among MS patients and the general
population
Employment among MS patients was compared to the
employment rates in the general population of Sogn and Fjordane
County by age and gender groups at December 31st in 2010
(Table 2). Only 33% of male and 32% of female MS patients aged
55–66 were employed compared to 75% of men and 69% of
women in the general population.
Univariate analyses of factors associated with
employment in MS
A total of 213 patients were available for evaluation of
employment status (full-time and part-time) (Table 3). The
employment rate among the patients was forty five percent
(45.1%), of whom 19.2% patients were full-time employed. Part-
time employees constituted 25.8% of the employed population
(RRMS; 33.9%, SPMS; 20.3% and PPMS 7.4%) (p,0.001) (data
Table 1. Socio-demographic and clinical characteristics in multiple sclerosis (MS); Relapsing-remitting MS, Secondary progressive
MS and primary progressive MS.
Variables
Total population
(n=213) RRMS (n=112) SPMS (n=74) PPMS (n=27) P value
Missing
observations#
Age at onset, yrs, mean (±SD)* 32.7 (69.9) 31.2 (69.0) 30.4 (68.0) 45.6 (68.3) ,0.001 0
Time from onset to diagnosis,
yrs, median (IQR)***
4.0 (68.0) 3.0 (67.0) 7.0 (68.0) 2.0 (65.0) 0.001 0
Disease duration, yrs, mean (± SD)* 18.9 (611.5) 13.9 (69.4) 27.3 (610.8) 16.9 (67.8) ,0.001 0
Gender**
Female, n (%) 147 (69.0) 84 (75.0) 52 (70.3) 11 (40.7) 0.002
Male, n (%) 66 (31.0) 28 (25.0) 22 (29.7) 16 (59.3) 0.002 0
Married/cohabitant, n (%)** 155 (72.8) 85 (75.9) 49 (66.2) 21 (77.8) 0.29 0
Education**
More than 12 years (.), n (%) 62 (29.1) 36 (32.1) 21 (28.4) 5 (18.5) 0.37 0
Onset symptoms**
Visual-sensory (yes), n (%) 98 (50.5) 56 (50.0) 39 (52.7) 3 (11.1) ,0.001 0
Brainstem-cerebellar (yes), n (%) 50 (26.0) 31 (27.7) 15 (20.3) 4 (14.8) 0.27 0
Pyramidal (yes), n (%) 36 (18.5) 19 (17.0) 9 (12.2) 8 (24.6) 0.12 0
Fatigue (FSS), median (IQR)*** 5.3 (62.0) 5.0 (62.0) 5.6 (62.0) 6.1 (62.0) 0.061 39
Disability (EDSS), median (IQR)*** 4.0 (63.0) 3.0 (62.0) 6.0 (63.5) 5.5 (62.8) ,0.001 17
Depression (present; BDI-D), n (%)** 11 (6.5) 8 (8.9) 3 (5.1) 0 (0.0) 0.30 44
Anxiety (present; BDI-A), n (%)** 32 (18.7) 16 (17.4) 14 (23.3) 2 (10.5) 0.41 42
Chronic pain (present) n (%)** 95 (55.9) 57 (60.0) 28 (50.0) 10 (52.6) 0.47 16
Disease modulating
therapy (yes), n (%)**
56 (27.1) 44 (40.4) 10 (14.1) 2 (7.4) ,0.001 6
*P-values (crude) were calculated from analysis of variance (ANOVA), a=0.05.
**P-values (crude) were calculated from chi-square analysis (Fischer exact test), a=0.05.
***P-values (crude) were calculated from Kruskal Wallis; a= 0.05.
Missing observations#; n (number of missing values) ranging from 0–44.
FSS: Fatigue Severity Scale; EDSS: Expanded Disability Status Scale; BDI: Beck Depression Inventory, RRMS: relapsing-remitting MS, SPMS: secondary progressive MS,
PPMS: primary progressive MS.
doi:10.1371/journal.pone.0103317.t001
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not shown). About 66% of RRMS patients were full-time
employed in comparison with 24.3% of SPMS and 14.8% of
PPMS (p,0.001) (Table 3). A significant variation in employment
rate between the three EDSS groups (0–3, 3.5–6, .6) was seen,
and patients with an EDSS score between 0–3 had the highest
employment rate (70.8%) (p,0.001). No significant differences
between employed patients versus unemployed patients were seen
regarding gender (p = 0.41), marital status (p = 0.97), visual-
sensory (p = 0.11), brainstem-cerebellar (p = 0.26) and pyramidal
onset symptoms (p = 0.78). Type of occupation (p= 0.26), presence
of chronic pain (p= 0.42), depression (p = 0.23) and anxiety
(p = 0.18) were not statistically significant in relation to employ-
ment (Table 3a). Mean age at onset (p = 0.03), disease duration
(p,0.001) and mean score of fatigue (p,0.001) in employed MS
patients were significantly lower than in unemployed patients
(Table 3). Among patients with higher levels of education; 56.5%
of patients were employed compared to 40.4% of patients with
lower education (OR 1.91, p = 0.03). Employed patients received
disease modulating therapy (DMT) more frequently than non-
employed patients (p = 0.02) (Table 3). Of the patients not being
employed; 7 patients were on sick leave, two were students, eleven
patients received retirement pension and 97 patients received
disability pension (data not shown).
Multivariate analyses of factors associated with
employment in MS
Multivariate analysis revealed that lower age at onset
(OR=0.93, p = 0.004), shorter disease duration (OR=0.93,
p = 0.020), higher education (OR=2.28, p = 0.048) less fatigue
(OR=0.73, p = 0.011) and lower level of neurological disability
(p = 0.001) were independently associated with employment
(Table 4). The goodness of fit test had a p-value equal 0.97
demonstrating a good fit for our model. A total of 172 (80.7%)
patients were included in this final model.
Discussion
This study set out with the aim of evaluating employment status
in a county based MS population and to investigate characteristic
demographic and clinical features in MS-subtypes. One notable
finding was the clear differences in employment rate in the various
subtypes of MS. In the present study we found that 66.1% of
patients with RRMS were employed full-time or part –time. In
comparison, only 24.3% of SPMS patients and 14.8% of PPMS
patients were employed. These findings are in line with two former
studies, showing that patients with RRMS with lower disability
levels have a higher employment rate than patients with
progressive types of MS with more pronounced disabilities [21,22].
Epidemiological differences between RRMS and PPMS were
further identified in our cohort. In the present study, more males
(59%) than females were affected by PPMS, corresponding to
previous reports on gender distribution in PPMS [23]. Patients
with PPMS were older at onset, had predominately motor
symptoms at onset, had higher disability levels and were more
frequently unemployed compared to patients with RRMS and
SPMS. These results are largely consistent with a previous
descriptive study on PPMS in Northern Ireland and UK [24].
Binary logistic regression analysis showed the importance of
disease duration on employment. The average disease duration of
employed MS patients in the present study was 7 years shorter
than among unemployed patients. Patients with RRMS had a
mean disease duration of 13.9 years, approximately half that of
SPMS at 27.3 years, and less than in PPMS; 16.9 years. The
impact of disease duration on employment longevity has been
shown by others [25,26]. Reportedly, between 50–80% of
unemployed MS patients have left work within 10 years post
diagnosis [26]. Nonetheless, at an average disease duration of
nearly 19 years, almost half (45%) of the MS population were still
employed either full- time or part- time, a somewhat larger
proportion than in other similar studies [12,27].
In the present study, lower age at onset was independently
associated with employment, confirming previous studies [3,9,13].
MS patients with a current working engagement were approxi-
mately three years younger at initial onset of MS than unemployed
patients. Also; an average 10 year age gap separated the employed
MS patients from the unemployed patients. This discrepancy in
mean age between employed patients contra unemployed patients
may reflect legislative protection or flexibility of working practices
that facilitate young employees with chronic diseases in Norway.
Also, there are welfare benefits awarding middle aged residents
with chronic diseases in Norway that may motivate patients to
leave workforce early. The national welfare benefits may explain
why age plays a different role in studies of employment in MS.
We could not detect any independent relation of disease
modulating therapy on employment, confirming a previous study
from UK (5) [28]. However a short –term prospective study has
indicated some beneficial effects on employment (30). Our study
included a cross-sectional population based cohort of patients with
a mean disease duration of almost 20 years, implying that some
patients have not received any treatment at all, and others may
have received treatment in more advanced stages of the disease.
Thus a prospective study design would have been preferable to
study DMT effects on employment.
The disability levels in MS were lower in RRMS. We found less
severe disability to be independently associated with current
employment. These results are consistent with other studies
[3,4,22]. Fifty seven percent of employed MS patients had EDSS
Table 2. Employment rates (full time and part time) in 2010 among the general population and MS-patients in Sogn og Fjordane
County.
Age groups General Population Employment rates (%) MS population Employment rates (%)
men women men women
20–24 years 71.9 68.0 100 100
25–39 years 87.5 82.9 58.3 68.8
40–54 years 90.6 87.8 44.0 51.6
55–66 years 75.0 68.8 33.3 32.4
doi:10.1371/journal.pone.0103317.t002
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Table 3. Univariate analysis of factors associated with employment in MS.
Variables All patients (n =213) Employed (n=96) Unemployed (n=117) OR (95% CI) P value
Age at onset, yrs, mean(±SD)* 32.7(69.9) 31.1 (68.9) 34.0 (610.4) 0.97 (0.94–0.99) 0.03
Disease duration, yrs, mean (±SD)* 18.9 (611.5) 15.1 (610.0) 22.1 (611.8) 0.94 (0.91–0.96) ,0.001
Gender, n (%)**
Male 66 (31) 27 (40.9) 39 (59.1) 1 0.41
Female 147 (69) 69 (46.9) 78 (53.1) 1.28 (0.71–2.30)
Marital status, n (%)**
Single 58 (27) 26 (44.8) 32 (55.2) 1 0.97
Married/cohabitant 155 (73) 70 (45.2) 85 (54.8) 0.99 (0.54–1.81)
Education, n (%)**
#12 years 151 (71) 61 (40.4) 90 (59.6) 1 0.03
.12 years 62 (29) 35 (56.5) 27 (43.5) 1.91 (1.05–3.47)
Disease course, n (%)**
RRMS 112 (52.6) 74 (66.1) 38 (33.9) 1 ,0.001
SPMS 74 (34.7) 18 (24.3) 56 (75.7) 0.17 (0.09–0.32)
PPMS 27 (12.7) 4 (14.8) 23 (85.2) 0.09 (0.03–0.28)
Occupation, n (%)**
Light physical 106 (50.5) 52 (49.1) 54 (50.9) 1 0.26
Heavy physical 104 (49.5) 43 (41.3) 61 (58.7) 0.73 (0.42–1.26)
EDSS, categorized, n, (%)**
0–3 72 (17) 51 (70.8) 21 (29.2) 1 ,.001
3.5–6 91 (43) 36 (39.6) 55 (60.4) 0.27 (0.14–0.52)
.6 33 (40) 2 (6.1) 31 (93.9) 0.027 (0.006–0.12)
Fatigue, total (±SD)* 5.0 (61.6) 4.5 (61.5) 5.4 (61.6) 0.67 (0.54–0.82) ,0.001
Depression (BDI), n (%)**
No 158 (93) 73 (46.2) 85 (53.8) 1 0.23
Yes 11 (7) 3 (27.3) 8 (72.7 ) 0.44 (0.11–1.70)
Anxiety (BDI), n (%)**
No 139 (81) 66 (47.5) 73 (52.5) 1 0.18
Yes 32 (19) 11 (34.4) 21 (65.6) 0.58 (0.26–1.29)
Chronic pain, n (%)**
No 75 (44) 37 (49.3) 38 (50.7) 1 0.42
Yes 95 (56) 41 (43.2) 54 (56.8) 0.78 (0.44–1.43)
Onset symptoms**
Visual-sensory
No 115 (54) 46 (40.0) 69 (60.0) 1 0.11
Yes 98 (46) 50 (51.0) 48 (49.0) 1.56 (0.90–2.69)
Brainstem-cerebellar
No 163 (76.5) 70 (42.9) 93 (57.1) 1 0.26
Yes 50 (23.5) 26 (52.0) 24 (48.0) 1.44 (0.76–2.71)
Pyramidal
No 177 (83) 79 (44.6) 98 (55.4) 1 0.78
Yes 36 (17) 17 (47.2) 19 (52.8) 1.11 (0.54–2.27)
MS course at onset**
RRMS 186 (87) 91 (48.9) 95 (51.1) 1 0.005
PPMS 27 (13) 5 (18.5) 22 (81.5) 0.24 (0.08–0.66)
Disease modulating therapy
No 151 (73) 61 (40.4) 90 (59.6) 1 0.02
Yes 56 (27) 33 (58.9) 23 (41.1) 2.12 (1.13–3.95)
*P-values (crude) were calculated from analysis of variance, a = 0.05.
**P-values (crude) were calculated from chi-square analysis (Fischer exact test), a = 0.05.
doi:10.1371/journal.pone.0103317.t003
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scores of three or less (fully ambulatory without aid). The
likelihood of being employed varied significantly according to
EDSS scores. MS patients with an EDSS score between 0–3 had a
three- fold likelihood of being employed compared to MS patients
with an EDSS score ranging from 3.5–6. In general, an EDSS
score above 5 is associated with marked preclusion of daily
activities [16]. Our results are consistent with a multinational MS
survey that found stable MS to be the main reason among
employed MS patients for remaining at work [29].
In the present study less severe fatigue was independently
associated with employment. Univariately, employed MS patients
had an average score of 1.0 point lower FSS than unemployed
patients. Fatigue has also been found to play an important role
related to changes in occupational status in numerous previous
studies [3,4,7,10,21,30], and was rated as the commonest factor
associated with leaving the workforce prematurely [29]. Fatigue is
also the factor MS patients themselves believe to cause their own
unemployment [1]. This could possibly be explained by the
frequent presence of fatigue in MS, but also to its debilitating
effects on both physical and mental health.
Highly educated patients had more than a twofold risk of being
employed compared to patients with less education. The onset of a
chronic illness at an early age may be disruptive to the education
process. In MS, however, disease onset is usually between 30–40
years of age, at an age where most patients would have completed
their education and started a working career. Higher education is
associated with better job opportunities and a greater likelihood of
being employed at all with better employment benefits and higher
wages [31]. In addition to economic benefits, higher education
represents social advantages including sense of control, social
standing and greater influence over own working conditions [32].
Higher educated individuals are also more likely to practice health
promoting behaviors such as to abstain from smoking and attend
regular health check-ups [32]. All reasons that could explain the
higher risk of employment among highly educated MS patients.
Type of occupation (heavy versus light physical job) did not
influence employment status among the MS patients. This finding
is in accordance with two previous studies that also found
occupation types to be unrelated to employment [11,12].
However, none of these studies, including ours, examined other
important working conditions like flexible work schedules and
other important workplace accommodations. Numerous working
conditions in addition to jobs demanding physical strength were
examined in Verdier-Taillefer et al. case-control study on factors
related to unemployment among MS patients, and this study
found that jobs requiring physical strength increased the odds of
unemployment [21].
The present study was a cross-sectional cohort study, meaning
that we could not predict causality between work ability and the
different variables studied. In addition, future studies should also
address issues not pursued in our study such as cognitive functional
tests to assess possible relations between cognitive disability and
employment. In addition, we did not assess environmental work
factors that could influence employment, such as support by co-
workers and close family, the ability to rest at work and the
relation between employer and employee at the work place.
We began this research with the purpose of gaining a better
understanding of the reasons related to work ability in MS. From
descriptive analyzes, we observed a significantly higher employ-
ment rate among patients with RRMS than in patients with
progressive types of MS, PPMS in particular. The final
multivariate results showed that highly educated MS patients with
lower age at onset, shorter disease duration and less fatigue and
disability were more likely to be employed. These findings provide
important insight and understanding of the underlying demo-
graphic and disease specific factors related to employment
opportunity in MS. This suggests the need for legislative practice
and environmental adjustments at the workplace to improve
working ability among less educated, fatigued and disabled MS
patients.
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Table 4. Multivariate analysis of factors associated with employment in MS*.
Variables OR (95 %CI) P value**
Age at onset, yrs, OR (95 % CI) 0.93(0.89–0.98) 0.004
Disease duration, yrs, OR (95 % CI) 0.93 (0.89–0.98) 0.02
Education, OR ( 95 % CI)
#12 years 1 0.048
.12 years 2.28 (1.01–5.17)
EDSS, categorized, OR ( 95 % CI)
0–3 1 0.001
3.5–6 0.34 (0.15–0.77)
.6 0.05 (0.01–0.26)
Fatigue OR ( 95 % CI) 0.73 (0.57–0.93) 0.011
*n = 172.
**p value#0.05 calculated from binary regression analysis.
doi:10.1371/journal.pone.0103317.t004
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